Direct injection HPLC micro method for the determination of voriconazole in plasma using an internal surface reversed-phase column

Biomedical Chromatography

Volumn 18, Issue 9, 2004, Pages 719-722

  Péhourcq, Fabienne ^a,c   Jarry, C ^b   Bannwarth, B ^a  

^a EA 525 Diffusion Med/Pharmacodynam   (France)

^b Laboratoire de Pharmacochimie   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

HPLC; Internal surface reversed phase column; Micro method; Voriconazole

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; DRUG INTERACTIONS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PATIENT TREATMENT; PLASMA STABILITY;

ANTIFUNGALS; CHROMATOGRAPHIC METHODS; DIRECT PLASMA INJECTIONS; HPLC; INTERNAL SURFACE REVERSED-PHASE COLUMN; INTERNAL SURFACES; MICRO METHOD; PLASMA SAMPLES; REVERSED-PHASE COLUMNS; VORICONAZOLE;

DIRECT INJECTION;

ACETONITRILE; BUFFER; POTASSIUM DIHYDROGEN PHOSPHATE; REAGENT; VORICONAZOLE;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STABILITY; DRUG STRUCTURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PATIENT CARE; PH; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIATION DETECTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STORAGE TEMPERATURE; TIME; ULTRAVIOLET RADIATION;

EID: 9944242094     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.383     Document Type: Article

References (7)

1. Gage R and Stopher DA. A rapid HPLC assay for voriconazole in human plasma. Journal of Pharmaceutical and Biomedical Analysis 1998; 17: 1449.
2. Jeu LA, Piacenti FJ, Lyakhovetskiy AG and Fung HB. Voriconazole. Clinical Therapeutics 2003; 25: 1321.
3. Lazarus HM, Blumer JL, Yanovich S, Schlamm H and Romero A. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. Journal of Clinical Pharmacology 2002; 42: 395.
4. Pennick GL, Clark M, Sutton DA and Rinaldi MG. Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrobial Agents and Chemotherapy 2003; 47: 2348.
5. Perea S, Pennick GJ, Modak A, Fothergill AW, Sutton DA, Sheehan DJ and Rinaldi MG. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrobial Agents and Chemotherapy 2000; 44: 1209.
6. Purkins L, Wood N, Ghahramani P, Greenhalgh K, Allen MJ and Kleinermans D. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Antimicrobial Agents and Chemotherapy 2002; 46: 2546.
7. Stopher DA and Gage R. Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column. Journal of Chromatography B 1997; 691; 441.